A Randomized,Double-Blind,Multi-Center Clinical Trial with Butenafine Hydrochloride 1% Aerosol Versus Bifonazole 1% Aerosol for the Treatment of Tinea Pedis,Tinea Corporis or Tinea Cruris
LI Min1, GU Jun2, BI Zhi-gang3, SHEN Yong-nian1, LÜ Gui-xia1, WANG Ying2, ZHANG Mei-hua3, LIU Wei-da1
Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China
LI Min, GU Jun, BI Zhi-gang, SHEN Yong-nian, LÜ Gui-xia, WANG Ying, ZHANG Mei-hua, LIU Wei-da. A Randomized,Double-Blind,Multi-Center Clinical Trial with Butenafine Hydrochloride 1% Aerosol Versus Bifonazole 1% Aerosol for the Treatment of Tinea Pedis,Tinea Corporis or Tinea Cruris[J].Chinese Journal of Dermatology, 2005, 38(8): 474-477.
[1] Reyes BA, Beutner KR, Cullen SI, et al. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis. Int J Dermatol, 1998, 37:450-453 [2] Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine,a new antifungal agent. J Am Acad Dermatol, 1997, 37(2 Pt 1):231-235. [3] Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris:a multicenter, vehicle-controlled,double-blind trial. J Am Acad Dermatol, 1997, 36(2 Pt 1):S20-S24. [4] Savin R, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis:a multicenter, double-blind trial. J Am Acad Dermatol,1997, 36(2 Pt 1) :S15-S19. [5] Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol, 1997, 36(2 Pt 1):S9-14. [6] Odom RB. Update on topical therapy for superficial fungal infections:focus on butenafine. J Am Acad Dermatol, 1997, 36 (2 Pt1):S1-S2.